Thrombosis-associated hypofibrinogenemia: novel abnormal fibrinogen variant FGG c.8G>A with oxidative posttranslational modifications

被引:5
作者
Ceznerova, Eliska [1 ,2 ]
Kaufmanova, Jirina [2 ]
Stikarova, Jana [1 ]
Pastva, Ondrej [1 ]
Louzil, Jan [1 ]
Chrastinova, Leona [1 ]
Suttnar, Jiri [1 ]
Kotlin, Roman [1 ]
Dyr, Jan Evangelista [1 ]
机构
[1] Inst Hematol & Blood Transfus, Dept Biochem, U Nemocnice 2094-1, Prague 2, Czech Republic
[2] Univ Chem & Technol Prague, Dept Biochem & Microbiol, Tech 5, Prague 6, Czech Republic
关键词
fibrinogen; hypofibrinogenemia; oxidative stress; posttranslational modifications; thrombosis; MESSENGER-RNA DECAY; CLOT FORMATION; MUTATION; POLYMERIZATION; FIBRINOLYSIS; ELECTRON; DYSFIBRINOGENEMIA; FEATURES; PLASMA; SITE;
D O I
10.1097/MBC.0000000000001125
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Here, we present the first case of fibrinogen variant FGG c.8G>A. We investigated the behaviour of this mutated fibrinogen in blood coagulation using fibrin polymerization, fibrinolysis, fibrinopeptides release measurement, mass spectrometry (MS), and scanning electron microscopy (SEM). The case was identified by routine coagulation testing of a 34-year-old man diagnosed with thrombosis. Initial genetic analysis revealed a heterozygous mutation in exon 1 of the FGG gene encoding gamma chain signal peptide. Fibrin polymerization by thrombin and reptilase showed the normal formation of the fibrin clot. However, maximal absorbance within polymerization was lower and fibrinolysis had a longer degradation phase than healthy control. SEM revealed a significant difference in clot structure of the patient, and interestingly, MS detected several posttranslational oxidations of fibrinogen. The data suggest that the mutation FGG c.8G>A with the combination of the effect of posttranslational modifications causes a novel case of hypofibrinogenemia associated with thrombosis.
引用
收藏
页码:228 / 237
页数:10
相关论文
共 60 条
[1]   Fibrin(ogen) and thrombotic disease [J].
Ariens, R. A. S. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 :294-305
[2]   The molecular basis of quantitative fibrinogen disorders [J].
Asselta, R. ;
Duga, S. ;
Tenchini, M. L. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (10) :2115-2129
[3]   Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 val->Asp) [J].
Brennan, SO ;
Hammonds, B ;
George, PM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) :2854-2858
[4]   Benign FGB (148Lys→Asn, and 448Arg→Lys), and novel causative γ211Tyr→His mutation distinguished by time of flight mass spectrometry in a family with hypofibrinogenaemia [J].
Brennan, Stephen O. ;
Mangos, Hilda ;
Faed, James M. .
THROMBOSIS AND HAEMOSTASIS, 2014, 111 (04) :679-684
[5]   Oxidation-induced modification of the fibrinogen polypeptide chains [J].
Bychkova, A. V. ;
Vasilyeva, A. D. ;
Bugrova, A. E. ;
Indeykina, M. I. ;
Kononikhin, A. S. ;
Nikolaev, E. N. ;
Konstantinova, M. L. ;
Rosenfeld, M. A. .
DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2017, 474 (01) :173-177
[6]  
Cai Zhiyou, 2013, J Biochem Pharmacol Res, V1, P15
[7]   MASS-LENGTH RATIO OF FIBRIN FIBERS FROM GEL-PERMEATION AND LIGHT-SCATTERING [J].
CARR, ME ;
SHEN, LL ;
HERMANS, J .
BIOPOLYMERS, 1977, 16 (01) :1-15
[8]   Protein modelling to understand FGB mutations leading to congenital hypofibrinogenaemia [J].
Casini, A. ;
Vilar, R. ;
Beauverd, Y. ;
Aslan, D. ;
Devreese, K. ;
Mondelaers, V. ;
Alberio, L. ;
Gubert, C. ;
de Moerloose, P. ;
Neerman-Arbez, M. .
HAEMOPHILIA, 2017, 23 (04) :583-589
[9]   Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management [J].
Casini, A. ;
Neerman-Arbez, M. ;
Ariens, R. A. ;
De Moerloose, P. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (06) :909-919
[10]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237